
The FDA has announced a public workshop entitled “Clinical Considerations of Risk in the Postmarket Environment." The purpose of the workshop is to provide a forum for an interactive discussion on assessing changes in medical device risk as quality and safety situations arise in the postmarket setting when a patient, operator, or member of the public actually uses the device. For details and registration, please see: http://www.fda.gov/ MedicalDevices/NewsEvents/ WorkshopsConferences/ ucm436365.htm
No hay comentarios:
Publicar un comentario